Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 133,149 shares at $10.00 ($1.3M) on 2021-02-16, disclosed to the SEC on 2021-02-17.
Open-market sale of $1.3M PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |